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Key Practitioner Message 
 CFS is a debilitating condition which is difficult to treat successfully; first line 
recommended treatments achieve only moderate effect sizes 
 
 Anxiety, particularly about health, is reported to be common in CFS. However, 
anxiety is not specifically targeted within treatment and may negatively influence 
outcome due to the potentially mutually maintaining nature of these complex 
conditions 
 
 The present study demonstrates that an integrated treatment approach designed to 
encompass physical and psychological symptoms yields reliable and clinically 
significant outcomes in 50% of time recommend for first line treatments.  
 
 Results reflected non-case level status for both CFS and health anxiety at end of 
treatment, in addition to reductions across all clinical measures.   
 
 This study demonstrates the fundamental importance of an individualised, rather than 
generic treatment approach to complex cases; the ‘meaning’ of experience is a central 
tenet within a cognitive approach which should be reflected in treatment. 
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Abstract 
Objectives.  CFS is a debilitating condition which affects 0.2-0.4% of the population.  
First line treatments are Cognitive Behaviour Therapy or Graded Exercise Therapy; 
however these treatments yield only moderate effect sizes. Emerging research 
suggests that anxiety about health may be common in CFS.  Health anxiety treatment 
models demonstrate good therapeutic outcomes however these models have yet to be 
applied to CFS. This paper describes the application of a novel cognitive behavioural 
approach to the treatment of both physical and anxiety related symptoms in a patient 
with CFS/ME, and furthermore presents a conceptual hypothesis regarding the 
mutually maintaining relationship between these two co-occurring conditions. 
Design. A single-case design was used, with pre, post and follow up data.  The 
cognitive behavioural model of health anxiety was adapted and delivered as an eight 
session intervention. The intervention was driven by an individualised formulation 
developed collaboratively with the patient.   
Results.  The application of this approach generated reliable and clinically significant 
reductions in physical and psychological symptoms, which were maintained at 12 
month follow-up. The participant no longer fulfilled the criteria for CFS or health 
anxiety following eight treatment sessions.  The treatment approach was found to be 
agreeable to the patient. All treatment hypotheses were supported.  
Conclusions. An adapted cognitive behavioural approach to treating CFS and health 
anxiety yields positive results and shows promise for application to the broader CFS 
population.   
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Introduction 
Chronic Fatigue Syndrome (CFS) is a debilitating condition which is characterised by 
unexplained, ongoing and excessive fatigue that is not alleviated by rest. Other common 
symptoms including joint pain, sleep disturbances and cognitive difficulties (NICE, 2007). 
CFS can lead to significant disability and contribute to poor quality of life. Estimates 
suggest that the economic impact of CFS on employment and productivity is over £102 
million a year in the UK (Collin, Crawley, May, Sterne & Hollingworth, 2011). The 
aetiology of CFS remains poorly understood, with prevalence rates of CFS in the region of 
0.2-0.4% of the population (NICE, 2007). Despite high quality CFS treatment trials, a recent 
meta-analysis (Castell, Kazantzis & Moss‐Morris, 2011) indicated that the gold standard 
treatment of Cognitive Behaviour Therapy (CBT) for this condition (NICE, 2007) resulted 
in only moderate improvements overall (g=0.33) with small to moderate improvements 
across the domains of fatigue, functional impairment, depression and anxiety.  Furthermore, 
when CBT for CFS is delivered in routine practice settings, levels of fatigue, depression and 
anxiety have been shown to decrease, but not to the same extent as in clinical trial settings 
(Fernie, Murphy, Wells, Nikčević, & Spada, 2016). The small to moderate effect sizes found 
contrasts with large effect sizes found for CBT in other conditions such as anxiety (Olatunji, 
Cisler, & Deacon, 2010).  
 
Current approaches to CBT for CFS are based on an original model developed by Wessley 
(1991). This model suggests that a heightened focus on disease or signs of disease, serves to 
reinforce beliefs that there is an acute and on-going disease process and activity is reduced 
accordingly.  Surawy and colleagues (1995) subsequently extended Wessley’s model further 
to include a number of personality related factors in the development and maintenance of 
CFS (Surawy, Hackmann, Hawton, & Sharpe, 1995). However, findings related to the 
importance of personality factors are relatively inconclusive (van Geelen, Sinnema, Hermans, 
& Kuis, 2007). Surawy’s elaborated model was further adapted and tested for clinical utility, 
forming the basis for CBT interventions delivered across specialist CFS services (Deale, 
Chalder, Marks & Wessley, 1997). The PACE trial (White et al., 2011) reported the largest 
multi-centre trial for the application of the CFS model of CBT, however results reflected only 
moderate outcomes. The CBT model for CFS adopts a primarily behavioural approach: 
focussing on physical symptoms and working towards behavioural change through an activity 
management programme; there has been little emphasis on the interpretation and ‘meaning’ 
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of symptoms for the patient, which feature as a central tenet to the theory and clinical 
application of cognitive behaviour therapy (Beck, Rush, Shaw, & Emery, 1979, Beck, 1995; 
Kelly, 1963; Leventhal, Safer & Panagis, 1983). However, more recently researchers have 
reported an association between cognitive elements, such as conceptual thinking about 
symptoms and symptom focus, and symptom severity (Fernie, Maher-Edwards, Murphy, 
Nikcevic, & Spada, 2015; Maher-Edwards, Fernie, Murphy, Nikcevic, & Spada, 2012; 
Maher-Edwards, Fernie, Murphy, Wells, & Spada, 2011).   
 
There is a high level of psychiatric co-morbidity in CFS patients. For example, the PACE 
trial (White et al., 2011) identified that 56% of the N=147 CFS sample had co-morbid 
psychiatric diagnoses, two thirds of which were identified as anxiety disorders (Cella, White, 
Sharpe & Chalder., 2013). Although health anxiety was not reported in the PACE trial, 
clinical levels of anxiety related to health concerns were reported to range from 17.5% to 
24.7% across medical disorders (Tyrer et al. 2011). Preliminary data suggests that prevalence 
of health anxiety  in CFS could be as high as 69% (Daniels, Kacorova, & Brigden, in 
submission). It is unsurprising, given the complex nature of CFS/ME, the often protracted 
process of diagnosis by exclusion, and the lack of clear medical explanation for the aetiology 
of CFS/ME, that rates of health anxiety may be higher in this population.  
 
Current research into anxiety disorders and CFS suggests that these conditions share similar 
maintaining factors which can be understood from the perspective of cognitive-behavioural 
theories; such research also supports the hypothesis that cognitive and behavioural factors 
maintain both anxiety and CFS (Surawy et al., 1995; Salkovskis, 1996; Deale et al., 1997; 
Tyrer et al., 2011).  
 
The cognitive behavioural model of health anxiety  (Salkovskis & Warwick, 1986) is based 
on the notion that ambiguous health-relevant stimuli (including bodily variations and 
sensations, health information, medical consultations and so on) are subject to 
misinterpretation which informs behavioural responses such as hypervigilance to stimuli 
bodily sensations, avoidance, bodily monitoring and reassurance seeking in order to address 
health concerns. These responses, also known as Safety Seeking Behaviours (SSB), then 
negatively impact on the perception of bodily function and related illness concerns as part of 
a set of vicious circles which fuel and maintain psychological distress. SSB are considered to 
be a key component in the maintenance of the anxiety cycle through the mechanism of 
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prevention of disconfirmation: i.e. the patient is unable to test or critically appraise their 
health beliefs as they employ strategies that they perceive ensures ‘safety’, rather than 
confronting fears or consequences. The tendency to appraise ambiguous health-relevant 
stimuli negatively and catastrophically is driven by underlying self-referent beliefs about 
health and illness, which give such stimuli particular meaning for an individual (Salkovskis, 
1996). Similarly, CFS is characterised by the way an individual interprets the cause and 
meaning of bodily sensations and symptoms experienced (Afari & Buchwald, 2003). 
 
Early cognitive behavioural models of CFS suggested that illness beliefs and coping 
strategies are also key factors in the development and perpetuation of CFS. More specifically, 
Wessely (1991) defined the trajectory of this condition as commencing with a virus or illness 
of organic/biological origin which precipitates coping strategies shaped by illness beliefs. 
Wessley’s model postulates that a heightened focus on disease or signs of disease, serves to 
reinforce beliefs that there is an acute and ongoing disease process and activity is reduced 
accordingly. This was borne out empirically in the PACE trial, in which fear avoidance 
beliefs (i.e. fears that activity will make the symptoms worse) mediated change in both CBT 
and GET (Chalder, Goldsmith, White, Sharpe & Pickles, 2015). These beliefs are 
paradoxically unhelpful, as in chronic illness, sustained activity reduction leads to muscle 
deconditioning which is likely to exacerbate symptoms such as pain and fatigue, creating a 
vicious cycle of chronic fatigue and disability (Browne & Chalder, 2006).  Coping strategies 
such as activity reduction serve to mediate between the acute initial illness and the chronic 
syndrome (Moss-Morris, 2005).   In both health anxiety and CFS, increasing chronicity is 
accompanied by preoccupation with symptoms, a perceived lack of control and 
demoralisation (Moss-Morris, 2005). Furthermore, in both CFS and health anxiety, coping 
strategies employed to either maintain health status or prevent worsening of health, serve to 
maintain the difficulties.   
 
Despite the overlap in processes maintaining CFS and health anxiety, the health anxiety 
model has not previously been evaluated in CFS patients. However, a recent large scale RCT 
tested the efficacy of Cognitive behaviour therapy for Health Anxiety in Medical Patients, 
(known as the CHAMP trial), using a CBT formulation driven approach to treatment (Tyrer 
et al., 2014). In this trial, N=444 health anxious patients were recruited from cardiac, 
neurological, respiratory, endocine and gastroentrological clinics. They were randomly 
assigned to 5 to 10 sessions of CBT for health anxiety (CBT-HA) or standard care. The CBT 
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protocol emphasised the patient’s interpretation of their fears about their symptoms and 
formulating their worst fears, before considering alternative explanations and gathering 
evidence for these, whilst reducing SSBs (Tyrer et al., 2011). Outcomes reflected succesful 
application of CBT-HA across all patient groups over a 2 year period and cost neutral 
interventions.  
 
Given the theoretical overlap between underpinning mechanisms in CFS and health anxiety, 
it is plausible to suggest that an integrated treatment approach drawing on the CHAMP trial 
with medical patients, will yield positive results for a sub-group of CFS patients who present 
with co-morbid health anxiety. It is postulated that the mechanisms by which CFS and health 
anxiety are both similalrly maintained present as a complex and unique clinical challenge in 
treatment;  the striking overlap in theoretical underpinnings may dictate a formidable mutual 
maintenance of CFS and health anxiety, particularly when undetected.  It is suggested that 
while all CBT models are more similalr than they are different, the health anxiety model has 
tested utility across health conditions and features ‘meaning’ of the symptoms (i.e. self-
referrent beliefs) which is the essential component within the CBT-HA model and absent in 
the CBT model of CFS/ME, therefore the former model is considered the most appropriate 
application to treat the complex presentation of CFS and co-morbid health anxiety.  
 
The aim of the present study was firstly to pilot the CBT health anxiety model in CFS with 
co-morbid health anxiety  using a single case study design; secondly, to achieve reliable and 
clinically significant improvements across physical and psychological health dimensions, 
achieving non-case level status for the patient in both CFS and health anxiety. 
 
Method  
 
An AB case study design was utilised to explore the effectiveness of using an adapted 
cognitive behavioural treatment approach for CFS with health anxiety. Five time points for 
measurement were used: t1=baseline/pre-treatment; t2=mid treatment/wk6; t3=end of 
treatment/wk8; t4=follow-up/wk 12, t5=12 month follow up. 
 
The treatment was based on empirically grounded cognitive-behavioural models of health 
anxiety (Salkovskis, 1996) and CFS (Surawy et al., 1995, Deale et al., 1997), using the 
formulation driven CBT model for health anxiety  as described in Salkovskis, Warwick and 
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Deale (2003), and drawing on the work of Tyrer and colleagues (2014). Treatment was 
delivered by a clinical psychologist (JD) with extensive clinical experience of CFS and 
accreditation in using the CBT approach; specialist supervision was given by experts in 
health anxiety (PS) and CFS (HoD). 
 
Treatment was contracted to be eight 60 minute sessions in addition to two assessment 
sessions. A treatment rationale was given in the first session, and explicit consent was 
obtained for using CBT for health anxiety to treat CFS and co-morbid health anxiety. The 
initial two sessions were used to complete an assessment and develop a formulation which 
integrated CFS associated symptoms and health anxiety related symptoms. This was done by 
eliciting a recent episode where symptoms were particularly problematic, incorporating 
significant amounts of detail to illustrate the links between the cognitive, behavioural, 
emotional and physiological domains. The formulation formed the basis for treatment, where 
standard CBT techniques and interventions were used to test the ‘hypothesis A/hypothesis B’ 
approach (Salkovskis & Bass, 1997) which underpinned the patient led testing of safety 
behaviours and inter-session work.  
 
Measures 
M.M completed the following routine in-service questionnaire measures, the majority of 
which were used nationally across CFS services: 
 
Chalder Fatigue Scale  
The Chalder Fatigue Scale (Chalder et al., 1993) is an 11-item questionnaire covering both 
physical and mental fatigue with four response options per question (“Less than usual”, “no 
more than usual”, “more than usual” and “much more than usual”). Extensive research into 
the validity of this measure has been carried out (Deale, et al., 1997) and overall it is 
considered reliable (Chalder et al., 1993). This binary scoring method was used in the present 
study (0, 0, 1, 1). 
 
Visual Analogue Scale (VAS)  
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The Visual Analogue Scale is a self-report measure of pain. The scale is scored out of 100 
and the distance in mm across the line is measured and forms the participants’ score (no pain 
0-4mm, mild pain 5-44mm, moderate pain 45-74mm, severe pain 75-100mm). 
Visual Analogue Scales have been considered to be a reliable way to quantify levels of pain 
(Price, McGrath, Rafii & Buckingham, 1983).  
 
Self-Efficacy Questionnaire   
This six item questionnaire rates participants’ confidence on a Likert style scale from 0 (Not 
at all confident) to 10 (Completely confident) that they are able to manage various aspects of 
their long term condition to reduce the impact on their everyday life (Lorig, Sobel, Ritter, 
Laurent & Hobbs, 2000). The original authors note that the measure is suitably reliable. 
Higher scores indicate higher self-efficacy.   
 
Hospital Anxiety and Depression Scale (HADS)  
The Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983) is a 14 item 
questionnaire designed to separately measure both anxiety and depression with seven 
questions each.  Cronbach’s Alpha for both measures combined in a non-clinical sample 
being 0.86 (Crawford, Henry, Crombie & Taylor, 2001). Scores range from 0-3 on each 
question (0-7 normal, 8-11 mild, 12-14 moderate, 15+ severe). 
 
 
SF-36 Measure of functioning  
The short form-36 is a quality of life measure consisting of 36 questions which measure eight 
subscales, Physical Function, Bodily Pain, General Health, Vitality, Social Functioning and 
Role Emotional and Role Physical, two subscales which specifically measure restrictions as a 
result of physical or emotional difficulty (Jenkinson, Coulter & Wright, 1993). The SF-36 is 
considered to be reliable with a good test-retest reliability score (>0.75) (Brazier et al., 1992). 
Higher scores indicate better functioning.  
 
Epworth sleepiness scale  
The Epworth Sleepiness Scale (Johns, 1991) requires participants to rate how likely they are 
to fall asleep in certain situations, from 0 (Would never doze) to 3 (High chance of dozing). 
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A score of over 16 suggests the person is unusually sleepy by day, 10–24 range indicates that 
expert medical advice should be sought. Test-retest reliability by Johns (1992), using the 
same participants as the original research, was good (r=0.82) and Crohnbach’s Alpha score 
was good for patients (α = 0.88). 
 
Health anxiety Inventory (HAI)  
The Health Anxiety Inventory (Salkovskis, Rimes, Warwick & Clark, 2002) is an eighteen 
item measure in which participants select one of four statements for each question. The 
measure is reported to have suitable test-retest reliability (0.90) and good overall internal 
consistency (α = .89). Further research has also confirmed reliability (Rabiei, Kalantari, 
Asgari & Bahrami, 2013). Clinical cut off for health anxiety is ≥15, with severe health 
anxiety scoring ≥18.  
 
Case study: background and assessment  
 
M.M. was a 40 year old married white female with two young children.  At the time of 
referral, she was not working due to her health problems. Prior to the onset of her CFS, M.M 
had worked at a senior level within a large organisation. She had experienced a number of 
difficult life events over the previous years, and was unable to identify a specific trigger for 
the onset of her fatigue. However, she believed that stress had contributed to her developing 
CFS. M.M. presented with overwhelming fatigue, muscle pain, un-refreshing sleep, impaired 
memory and concentration, and joint pain. She met the Centre for Disease Control Fukuda 
diagnostic criteria (Fukuda et al., 1994), and was accepted into the specialist service for 
assessment.  
 
At assessment, M.M disclosed having experienced anxiety and depression in the past, which 
had been significantly ameliorated with CBT. She described herself as a worrier, with a 
recent history of panic attacks. To cope with her CFS symptoms, she employed a number of 
strategies which she perceived to be helpful. These included alternating rest, activity and 
sleep throughout the day within a highly detailed and rigid daily routine that she had 
developed, with the motivation of ensuring that she was able to meet the demands of her 
family and prevent a worsening of her symptoms. When M.M began to feel unwell, or 
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emotionally distressed by her symptoms, she would absent herself from the situation and 
rest/sleep or isolate herself for fear of behaving in a way she considered ‘horrible’. She would 
also look for ‘warning signs’ that her health was worsening (e.g. higher perceived need for 
sleep, ‘snappy’ responses, increased fatigue) so that she could take preventative action. 
 
M.M reported a strong loss of role and identity due to the pervasive and substantial reduction 
in her activities of daily living; resigning from her high level job due to health difficulties was 
particularly challenging. She reported feeling very restricted and trapped, that she was not 
living a normal life. M.M. reported unfavourable comparisons to others and her own life prior 
to the CFS. In addition to the disabling physical symptoms she experienced, M.M. reported 
significant changes to her lifestyle, including inability to sustain a social life, reduced 
activities with her children, and significant concerns relating to her inability to engage more 
fully in her relationship with her husband.   
 
Based on clinical material and empirical findings, the following hypotheses were developed 
for testing within treatment:  
 
Table 1: Treatment hypotheses 
Treatment Hypotheses 
1. Cognitive beliefs relating to CFS and CFS symptoms inform 
behavioural strategies which maintain CFS. Targeted cognitive 
restructuring (and associated behavioural experiments) will lead to 
a reduction in the 100% conviction that specific behaviours (i.e. 
SSB) are necessary to prevent a worsening of CFS/ME, and that a 
worsening will lead to collapse.  
2. Symptoms of CFS (specifically fatigue and pain) are maintained by 
behavioural strategies which are designed to prevent worsening of 
(CFS/ME) symptoms. Extinction of specific strategies identified in 
the formulation will lead to an improvement in the primary 
physical symptoms of fatigue (Chalder Fatigue Scale) and pain 
(VAS).    
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3. The health focused anxiety serves to exacerbate the CFS symptoms 
and vice versa; therefore, addressing both within an integrated 
approach will lead to reductions in both CFS symptoms (Chalder 
Fatigue Scale) and health anxiety (health anxiety inventory) as well 
as improvements in functioning (SF-36) and self-efficacy (self-
efficacy scale).  
 
 
Formulation 
 
As illustrated in the diagrammatic representation of the formulation, M.M.’s episodes of 
fatigue and associated symptoms were usually triggered by a perception of feeling ‘tired’. 
Once this appraisal of her physical state had been made, she experienced negative automatic 
thoughts related to perceived restrictions; M.M. believed that she possessed finite resources 
and therefore, perceived signs of tiredness would activate her assumptions that she would be 
unable to engage in further activity and that she ‘can’t cope/will collapse’ (100% conviction): 
M.M. believed that if she continued to engage in physical activity beyond her perceived 
capacity, this would both worsen her condition and ultimately lead to the revelation (to 
others) that she was an unpleasant and ‘horrible person’.   When operationalized, M.M. 
described her feared ‘horrible’ side as unreasonably angry behaviour that was unpleasant and 
would lead to rejection by others.  
 
Fear relating to her perceived inability to cope and the prospect of exposing this ‘horrible’ 
side was intolerable for M.M., and thus fuelled behavioural strategies designed to avoid 
further worsening of symptoms for these reasons. However, these strategies were 
counterproductive and not only prevented disconfirmation of her ability to cope, but also led 
to emotional and physical symptoms which paradoxically generated evidence consistent with 
her belief that she was unable to cope, e.g. further physical symptoms detected through 
hypervigilance were more likely to reinforce her belief that she was unable to cope and is at 
risk of collapse. This consequently led to an increase in triggering episodes due to the 
hypervigilance to the perceived sensation of tiredness. This further perpetuated one of several 
cycles which  ultimately resulted in a restricted existence with entrenched behaviours 
maintained by the meaning given to the perceived sensation of tiredness (I can’t cope/ I’m 
going to be  horrible/collapse).  
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Figure 1: Formulation of presenting difficulties. 
 
Overview of treatment 
 
Following the development of the formulation, early treatment sessions focussed on 
operationalising the meanings and appraisals of specific beliefs, for example: “I can’t 
cope/collapse” and the hidden “horrible” person.  The ‘worst case scenario’ for the beliefs 
were elicited, and belief ratings were established to ensure that change could be measured 
across treatment sessions.  Psychoeducation and discussion around the mind-body link served 
to higlight the overlap between the physical sensations of anxiety and physical symptoms 
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--- 
I will turn into a bad, 
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        Daytime nap 
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              Over-
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‘warning 
Signs’ 
 
All or nothing 
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associated with CFS/ME, and how normal bodily variations can be interpreted as signs of 
something worrying happening in the body.  This also served to highlight the counter-
productive role of symptom hypervigilance and was demonstrated through the use of body-
focus tasks, illustrating how increased attention can lead to symptoms or the intensifying of 
symptoms (Wells, 1999).  
Goals for treatment were established and activity monitoring was set up to give a clearer 
insight into the frequency and full repetoire of all behaviours employed in response to the 
interpretation of physical symptoms and prevention of the ‘worst case scenario’. The 
‘Hypothesis A, Hypothesis B’ (Salkovskis & Bass, 1997) concept was introduced as an 
underpinning approach to treatment, with the collaborative agreement that in order to 
ascertain whether M.M’s current ‘coping’ behaviours were helping /preventing the worst case 
scenario from happening, we would need to test them out. The ‘builder’s apprentice’ 
metaphor was used to facilitate this discussion of the scientists approach (Stott, Mansell, 
Salkovskis, Lavender, Cartwright-Hatton, 2010). Simply put, the metaphor describes the long 
suffering builder’s apprentice who holds up his newly built wall, for fear that it may fall or 
collapse if he does not support it.  The question is: how will he discover whether he needs to 
continue to hold up the wall? He must test it. This relates to evidence gathering within the 
scientist approach, specifically the testing of SSB.  
In M.M.’s case, hypothesis A/hypothesis B was as follows:  
A. I need to take measures to prevent a worsening of my CFS/ME, and if I do not prevent 
a worsening then I will be unable to cope and/or will collapse (belief rating 100%). 
B. I am taking measures to prevent a worsening of my CFS/ME, however these measures 
may be contributing to or maintaining the problem, rather than helping (belief rating 
0%). 
Cognitive strategies were employed to evaluate appraisals such as “I can’t cope” and 
challenge underlying beliefs that “being angry = I am a horrible person”.  For example, on 
examination, M.M. revealed evidence for ‘snappiness’ and other interpersonal behaviours 
commonly associated with tiredness or lack of sleep (e.g. irritability), however even at her 
worst she found no evidence of unreasonable behaviour that would constitute her definition 
of ‘horrible’, despite the agreement that ‘horrible behaviour’ does not necessarily equate to a 
horrible, unloveable person.  
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Common thinking errors were identified and considered in relation to how these might 
inform coping behaviours, such as ‘all or nothing’ thinking. Through discussion, review of 
the formulation and an invited critical review of her own coping strategies, M.M quickly 
concluded that ‘looking for trouble’ i.e. symptom hypervigilence was contributing to her 
symptom experience rather than preventing a feared catastrophe. The Socractic method was 
used to elicit how these behaviours prevented disconfirmation that she would ‘cope’ and 
would be unlikely to ‘collapse’ and the unintended consequences of increase anxiety and 
worry. Within 
the hypothesis 
A/B 
framework, 
behavioural experiments were employed to test beliefs relating to the need to ‘sleep/rest’ and 
the perceieved reliance on a rigid routine and the resultant effect on mood, physical 
sensations and beliefs. These experiments were patient led and set as homework by the 
patient.   
Final sessions focussed on reviewing the formulation and evidence in favour of hypothesis 
A/B: all behaviours previously considered necessary to prevent a worsening of symptoms 
were abandoned, which facilitated M.M in reaching all of her therapy goals. All maintaining 
cycles were judged to have been broken, and she no longer believed she was unable to cope, 
or on the verge of unleashing a ‘horribleness’ each time she perceived an increase in 
symptoms. A therapy blueprint was produce by the patient and based on the treatment notes. 
 
Results 
At commencement of therapy, M.M. scored within the clinical range on the Chalder Fatigue 
Scale, HAI, and VAS, with mildly elevated clinical range scores on the HADS anxiety scale.  
Scores across all measures were below the clinical thresholds at session eight and at follow 
up. Scores on the Chalder Fatigue Scale reduced from full complement (11/11) to no fatigue 
related problems (0/11); this infers a complete absence of fatigue. Pain  
scores reflected no pain where pain was ‘moderate’ at baseline. Anxiety and health anxiety 
reduced to sub-clinical levels.  
Table 2: Outcome data baseline to 12 month follow up 
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Table 3: Reliable and clinical significant change 
Baseline 11 45 26 9 6 17 4 15 
T2 - S6 8 20 40 9 1 22 4 11 
T3 – S8 7 15 50 5 2 25 4 7 
T4 – 4 week FU 0 0 54 6 2 30 3 3 
12 month 
follow up 
2 0 50 6 1 32 3   
Measure Points change 
required for 
Reliable Change 
Index 
Points 
change 
required for 
Clinically 
significant 
change 
Patient’s 
change in 
scores 
from 
baseline 
to post-
treatment 
Reliable 
change? 
Clinically 
significant 
change? 
*Chalder 
Fatigue Scale 
3 (Chilcot, 
Norton, Kelly & 
Moss-Morris, 
2015) 
4 (Sabes-
Figuera et 
al., 2012) 
4 Y Y 
Hospital Anxiety 
and Depression 
Scale – Anxiety 
5 (Morley, 
Williams & 
Hussain., 2008) 
8 (Morley et 
al., 2008) 
4 N N 
Hospital Anxiety 
and Depression 
Scale – 
5 (Morley et al., 
2008) 
8 (Morley et 
al., 2008) 
4 N N 
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Change in scores on the outcome measures were compared to published data on reliable and 
clinically significant change on these measures. Changes in the fatigue, health anxiety and 
pain measures were reliable and clinically significant (* denotes significance).  
 
The course of treatment was completed following eight treatment sessions as agreed; 
treatment success was attained using half of the recommended 16 sessions of CBT (NICE, 
2007). M.M. no longer met the Fukuda criteria for CFS at the completion of treatment.  
 
As part of the 12 month follow-up within the CFS service, M.M. completed a global 
impressions scale (Busner & Targum, 2007) which indicated optimum outcome of ‘very 
much better.’ M.M. reported that gains had been maintained within the 12 month period and 
that she had secured employment within that time. 
 
Discussion 
Depression  
*Health Anxiety 
Inventory 
4 (calculated 
based on info 
from Salkovskis 
et al., 2002) 
7.58 (Tyrer 
et al., 2014) 
8 Y Y 
SF-36 8.4 (Hays, 
Brodsky, 
Johnston, 
Spritzer & Hui, 
2005) 
- 8 N - 
Self-efficacy 
Scale 
  24   
Epworth 
Sleepiness Scale 
6 (Smith & 
Sullivan, 2007) 
- 4 N - 
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The present study piloted the use of an integrated treatment based on a health anxiety model 
in a patient with CFS and comorbid health anxiety. The success of the treatment as reflected 
in the measures and patient self-report provides preliminary evidence for the acceptability of 
this approach. Outcome data reflects non-case level scores at end of therapy and 12 month 
follow up, including both physical and anxiety/mood related symptoms. Furthermore this 
treatment approach yielded reliable and clinically significant outcomes across target measures 
following eight treatment sessions. M.M. reported significant functional improvements, 
reporting that she felt able to return to live a normal life.  This was further demonstrated by 
her ability to secure employment and report optimum outcome in the global impressions scale 
at 12 month follow up. Evidence generated and reported supports all treatment hypotheses 
outlined.   
The key aspect of cognitive behaviour therapy specifically employed and elaborated within 
this novel CFS intervention was the interpretation and meaning of symptoms. Although a 
cognitive shift can result from behaviour change (Beck, 1979), cognition is the cornerstone of 
any high integrity CBT intervention. M.M.’s interpretation of physical sensations were 
pivotal in shaping her responses to managing her CFS/ME; her ‘safety seeking behaviours’ 
were directed at avoiding a CFS related ‘collapse’ however they were ineffective, fuelled by 
anxiety and likely to be maintaining her CFS symptoms. M.M. had not previously taken a 
critical approach to her strategies: as illustrated in the builders apprentice metaphor (Stott, et 
al. 2010); she had not tested whether her strategies were actually holding up the wall (i.e. 
preventing her feared outcome), she assumed they were working because she had not reached 
her worst case scenario. Cognitive restructuring with the aid of behavioural experiments 
resulted in M.M. tentatively yet successfully withdrawing her hands from the wall to find that 
neither she nor the wall collapsed. M.M.s absolute belief conviction in hypothesis A shifted 
to absolute belief conviction in hypothesis B through the course of therapy, supporting 
treatment hypothesis one.  
 
Through the course of treatment M.M. was able to experiment with her SSB, which enabled 
her to challenge her anxiety related beliefs and generate evidence to disconfirm her fears, .i.e. 
that she was able to ‘cope’ with increased symptoms and that her hidden ‘horribleness’ was 
in fact normal responses to tiredness and feeling under resourced:  M.M. shifted to an 
acceptance that frustration, anger and exasperation were not emotional experiences unique to 
her, and that irritation and snappiness did not affirm her status as a ‘horrible’ person. M.M, 
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was able to test the necessity of her rigid routine by gradually expanding her bandwidth: she 
was surprised to find that she was able to engage in significantly more activities than she had 
anticipated, without the feared consequence of becoming unreasonably angry and hostile.   
 
M.M.’s abandonment of her SSB allowed her to engage more actively in life, breaking the 
cycles that were maintaining her symptoms: appropriately graded activity akin to Graded 
Exercise Therapy (albeit more informally conducted) is likely to have contributed to an 
amelioration of symptoms due to a reversal of deconditioning symptoms commonly found in 
CFS (Wearden et al., 2010). This supports treatment hypothesis two.  
 
The present treatment approach for CFS was based on the underlying supposition that CFS 
and health anxiety share similar maintaining mechanisms and theoretical roots and where 
presenting together, an integrated approach would yield amelioration of symptoms associated 
with both. This was achieved within 50% of the time recommended for current first line 
treatment (NICE, 2007) and maintained at 12 month follow up. We therefore conclude that 
this case study was a successful application of the model and that hypothesis three is 
supported.  
 
The ‘scientist’ approach was meaningfully utilised within treatment: using the ‘theory A/ 
theory B’ technique (Salkovskis & Bass, 1997) therapy progressed on a patient-led basis, 
enabling M.M. to explore her own beliefs at her own pace, taking ownership of the 
therapeutic process. M.M. reported that the scientific/critical approach to cognitive beliefs 
and assumptions was superlatively useful in the treatment approach.   
 
The Socratic, collaborative relationship that underpinned the course of treatment was 
palpably fundamental to the success of treatment; M.M. was highly engaged as an active 
participant in therapy, affirming the agreeability and accuracy of the treatment model 
throughout the therapy process through positive engagement. The ease of arriving at a shared 
formulation and continued understanding and agreement of the aims of therapy and how to 
achieve those aims reflected not only the acceptability of the approach, but also a high degree 
of socialization to the treatment model (Roos & Wearden, 2009), which may have acted as an 
active component in the therapy (Daniels & Wearden, 2011).  
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Agreement and acceptance of a psychologically based model has been an area of contention 
in CFS where rejection of treatment rationale or psychologically based treatments has been 
cited as barriers to treatment (Chew-Graham, Brooks, Wearden, Dowrick & Peters, 2008; 
Butler, Chalder, Ron & Wessely, 1991; Wearden, Riste, Chew-Graham & Peters, 2008). This 
has not been the case here; M.M. responded to the treatment approach with enthusiasm and 
rigour.   It is difficult to ascertain whether M.M. was unusual in her response to the treatment 
model, however a larger trial could test acceptability of the approach more fully.  
 
It is suggested that there are key differences between current routine treatment models and 
the present approach which may have contributed to the positive outcome.  Firstly, the 
underpinning model used in the present treatment is empirically grounded and has been 
developed and tested across patient groups, specifically developed for formulation-based 
application and therefore more suitable for patients with co-existing anxiety. Secondly, the 
current approach places an emphasis on the ‘meaning’ derived from patient symptoms; this 
meaning informs and precipitates the use of behavioural strategies and does not feature as a 
key component in standard CBT for CFS. It was evident from the intervention that core 
beliefs and feared outcomes were directly related to M.M’s strategies and the potency of this 
as a driver in CFS may be underestimated.  
 
There are inherent limitations using a single-case design, specifically that the findings cannot 
be generalized to the broader CFS population. However, a single-case study provides a 
legitimate trial of an experimental intervention and a basis for further treatment development 
(MRC, 2000) which looks promising.  This study would have benefitted from further baseline 
monitoring to establish a stable presentation prior to treatment and reliability of the treatment 
outcome. This does not negate the merit of the study, but the findings must be interpreted 
cautiously: M.M reported a history of anxiety however this was not evidenced objectively 
over multiple baseline time points, which would have been ideal.    
 
It is noted that while scoring the highest possible score on the Chalder Fatigue Scale and 
moderate levels of pain, M.M. did not represent a severe case of health anxiety. Future testing 
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of this approach for CFS should assume a controlled approach to recruitment to test utility of 
the treatment for those affected across a range of severity.  
 
Given the findings of the present study, future research should focus on testing the success of 
the intervention within a small trial or case series, specifically with CFS patients with higher 
levels of health anxiety.  With recently emerging phenotype based research identifying sub-
groups within CFS population, further testing of the model should be considered within this 
context.   
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